The FDA accepted an application for ivonescimab with chemotherapy for patients with lung cancer driven by EGFR changes after ...
New analysis has found that the FDA permits 25 cancer-causing chemicals in America's food, despite many of them being banned or tightly restricted in other countries.
An informational overview examining category context, publicly available product disclosures, and what consumers often ...
An informational overview examining category context, publicly available product disclosures, and what consumers often ...
Homer Glen is seeking $3 million in federal grants toward a sanitary sewer line extension and $1 million for water bill relief.
The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...
A new drug application (NDA) has been submitted to the FDA seeking approval of lirafugratinib (RLY-4008), a selective FGFR2 ...
New draft guidance from the FDA on multiple myeloma endpoints reflects the new technology available to assess disease and how patient journeys have changed with better treatments.
Life Biosciences plans to begin human clinical trials of a cellular rejuvenation therapy in optic neuropathies after ...
Zacks Investment Research on MSN
FDA accepts SMMT's application seeking approval for NSCLC drug
Summit Therapeutics SMMT announced that the FDA has accepted its biologics license application (BLA) seeking approval for ...
Pharmaceutical Technology on MSN
FDA’s new scheme to boost US manufacturing commences despite uncertainty
The PreCheck programme, first unveiled in June 2025, aims to speed up drug facility construction.
Ivonescimab's BLA acceptance is a milestone for PD-1/VEGF bispecific antibodies in the U.S., potentially transforming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results